Sectors
Health & Medicine
Launched
01/01/1999
Description
Koronis Pharmaceuticals (formerly VDA Pharma) has developed antiviral therapeutics based on Viral Decay Acceleration (VDA) – a novel drug mechanism.
Team Members
Lawrence Loeb
Scientific Advisor and Director of Medical Science Training Program at University of Washington
James Mullins
Scientific Advisor and Professor of Microbiology at University of Washington
John Essigman
Scientific Advisor and Professor of Toxicology and Chemistry at MIT
